Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Compare total market funds to determine which has the lowest fees, balancing expense ratios with diversification and performance history.
28,601 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Shares of Intel surged after a bullish Bank of America note projected a rapidly expanding server-CPU market, with AMD...
In 2026, Nvidia stock has cooled from its sky-high run. If you own NVDA, you’ll want a clear plan: trim profits, reba...
A clear spark lit up Rivian stock as the R2 SUV launch was confirmed. This piece breaks down what it means for the st...
A little-known micro-market has outpaced the broader S&P 500 by roughly fivefold in 30 days, highlighting AI hardware...
A dramatic daily swing has SpaceX briefly tumbling below Amazon in market cap. Here's how to judge which growth stock...
A small BTC sale by Strategy is not a capitulation. The firm says the move funds preferred stock distributions while ...
Wondering how to earn much while claiming Social Security without sacrificing your benefits? This guide explains the ...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
Two casino giants, two very different playbooks. This guide weighs Resorts International and Wynn Resorts to help you...
Dogecoin shot to fame and then faded, but savvy investors still wonder about its future. This guide breaks down the o...
Bitcoin cooled after a short burst higher, while Ethereum retraced from a six-week peak. The market posture remains c...